How big is the GCC In-Vitro Diagnostics Market?

The GCC In-Vitro Diagnostics Market size is expected to reach USD 2.07 billion in 2024 and grow at a CAGR of 5.10% to reach USD 2.66 billion by 2029. Read More

What is the current GCC In-Vitro Diagnostics Market size?

In 2024, the GCC In-Vitro Diagnostics Market size is expected to reach USD 2.07 billion. Read More

Who are the key players in GCC In-Vitro Diagnostics Market?

Abbott Laboratories., Danaher Corporation, F. Hoffmann-La Roche AG, Becton, Dickinson and Company and Sysmex Corporation are the major companies operating in the GCC In-Vitro Diagnostics Market. Read More

What years does this GCC In-Vitro Diagnostics Market cover, and what was the market size in 2023?

In 2023, the GCC In-Vitro Diagnostics Market size was estimated at USD 1.97 billion. The report covers the GCC In-Vitro Diagnostics Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the GCC In-Vitro Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

GCC In-Vitro Diagnostics Companies

This report lists the top GCC In-Vitro Diagnostics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the GCC In-Vitro Diagnostics industry.